Wuxi


Also found in: Encyclopedia, Wikipedia.

Wu·xi

also Wu·sih  (wo͞o′shē′)
A city of eastern China between Shanghai and Nanjing.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Wuxi

(ˈwuːˈʃiː; -ˈsiː) ,

Wusih

or

Wu-hsi

n
(Placename) a city in E China, in S Jiangsu province on the Grand Canal: textile industry. Pop: 1 192 000 (2005 est)
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

Wu•xi

or Wu•sih

(ˈwüˈʃœ)

also Wuhsi



n.
a city in S Jiangsu province, in E China. 826,833.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
Translations
無錫
References in periodicals archive ?
STA Pharmaceutical Co., Ltd., (WuXi STA)--a subsidiary of WuXi AppTec--announces that its Analytical Service Unit (ASU) in Shanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the U.S.
SHANGHAI, June 29, 2019 -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announces that it has been selected as one of MIT Technology Review's 50 Smartest Companies (TR50) for 2019.
WuXi Biologies plans to expand its new integrated biologics conjugation solution center to include commercial manufacturing in Wuxi City, China.
WuXi Biologics, a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has signed a strategic partnership letter of intent with a global vaccine leader, it was reported yesterday.
Biologics company WuXi Biologics said on Monday that WuXi Vaccines has entered into a Letter of Intent (LOI) for a strategic 20-year,USD3bn manufacturing and supply partnership with a global vaccine company.
7 May 2019 - China-based pharmaceutical and medical device company WuXi AppTec has acquired California, US-based clinical research services provider Pharmapace, Inc., the company said.
WuXi Biologics and Amicus Therapeutics announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200.
NetApp has partnered with WuXi NextCODE are working to improve health for people around the globe.
Securities and Exchange Commission, affirmed China-based Wuxi Construction and Development Investment Co., Ltd.'s (WCDI) Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDRs) at 'BBB+'.
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Immune Pharmaceuticals (Nasdaq: IMNP) ('Immune'), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced a development and manufacturing agreement for the production of bertilimumab, Immune's first-in-class anti-eotaxin-1 monoclonal antibody, Monday (7/9).
WuXi Biologics has selected 4,000 liter (L) Custom Single Run (CSR) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China.